Moonlake Immunotherapeutics (MLTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -24,572 | -12,219 | -64,506 | -48,038 | -33,297 |
| Depreciation Amortization | 7 | 3 | 165 | 9 | 6 |
| Accounts receivable | -403 | -161 | -68 | -452 | -408 |
| Accounts payable and accrued liabilities | 4,105 | 3,572 | -1,314 | -513 | -778 |
| Other Working Capital | -769 | 530 | -1,580 | -3,549 | -6,301 |
| Other Operating Activity | 449 | -750 | 11,410 | 8,245 | 5,832 |
| Operating Cash Flow | $-21,183 | $-9,024 | $-55,894 | $-44,298 | $-34,946 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 32,325 | 19,649 | -32,325 | -42,226 | N/A |
| PPE Investments | N/A | N/A | -16 | -16 | -16 |
| Investing Cash Flow | $32,325 | $19,649 | $-32,341 | $-42,242 | $-16 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | -15,000 | -15,000 | -15,000 |
| Common Stock Issued | 451,285 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 0 | 0 | 134,693 | 134,689 | 134,689 |
| Financing Cash Flow | $451,285 | $N/A | $119,693 | $119,689 | $119,689 |
| Exchange Rate Effect | -145 | -1 | 9 | 17 | -58 |
| Beginning Cash Position | 39,506 | 39,506 | 8,039 | 8,039 | 8,039 |
| End Cash Position | 501,787 | 50,129 | 39,506 | 41,205 | 92,708 |
| Net Cash Flow | $462,281 | $10,624 | $31,467 | $33,166 | $84,669 |
| Free Cash Flow | |||||
| Operating Cash Flow | -21,183 | -9,024 | -55,894 | -44,298 | -34,946 |
| Capital Expenditure | 0 | 0 | -16 | -16 | -16 |
| Free Cash Flow | -21,183 | -9,024 | -55,910 | -44,314 | -34,962 |